In addition, the expression of VEGFR1 was found to be attenuated in HUVECs after RUNX1 mRNA silencing, implicating that VEGFR1 may be a vital factor downstream of RUNX1-mediated angiogenesis and disease progression in NAFLD [36]. Here, FLT1 is linked to metabolic dysfunction-associated steatotic liver disease.